Dr Carmen Moreno

Declaration of Interests

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No
  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No
  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No
  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. Member of the Data Monitoring Board for a melatonergic agent for Servier since 2015. Consultant for a psychotherapeutic intervention in the context of vortioxetine study for Lundbeck.
  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No
  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. No
  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No
  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. No
  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. Attendance to Congress AEPNYA in 2014, travel and accomodation, pais by Lundbeck. Attendance to Congress WPA 2014, registration paid by Janssen
  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. Lundbeck vortioxetine study in children and adolescents with MDD
  21. If there is anything else you feel it necessary to disclose, please provide details below:
  22. I am currently National Coordinator of astudy with vortioxetine in children and adolescents with MDD by Lundbeck starting in 2016

Form completed on 3rd February 2017